Pancreatic Neoplasms
📧 Sign up to get email alerts when something new happens for Pancreatic Neoplasms.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2015-01-06EMA Refused: Masiviera (masitinib) — AB Science
The EMA refused approval for Masiviera (masitinib) for pancreatic neoplasms, with AB Science as the marketing authorization holder.
-
CLINICAL_TRIALS withdrawal · 2014-09-19Clinical Trial Update: Endoscopic Ethanol Ablation of Communicating Pancreatic Cystic Neoplasms [Phase 1]
A Phase 1 clinical trial investigating endoscopic ethanol ablation for communicating pancreatic cystic neoplasms was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-04-12Clinical Trial Update: Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary Cancer [Phase 2]
A Phase 2 trial comparing endoscopic-based stent strategy to bypass surgery for non-resectable periampullary cancers has been withdrawn.